![Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)](https://www.facingourrisk.org/cdn-cgi/image/width=400,height=300,fit=contain,format=webp/uploads/assets/research/images/611a947c531af.jpg)
Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
Clinicaltrials.gov identifier:
NCT03831698
Study Contact Information:
Contact: Clinical Trials Nurse Navigator by phone: 913-945-7552 or by email.
Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
About the Study
This study looks at how well omega-3 fatty acid ethyl esters (generic Lovaza) work in preventing colorectal cancer in patients with . Omega-3 fatty acids work by decreasing inflammation, or swelling, in the body, and suppressing certain chemicals in the body that are known to cause cancer. The addition of omega-3 fatty acids to patients' diets may help decrease colon inflammation or suppress cancer-causing chemicals in the body. NOTE: This study is no longer enrolling people.
NOTE: This study is no longer enrolling people.
NOTE: This study is no longer enrolling people.